Korsana Biosciences at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

Korsana Biosciences takes part in 2 sessions at ACT 2026 in San Antonio. Its program centres on vascular inflammation, from an introduction to the condition to how findings in nonclinical studies translate to patients.

OrganizationACT 2026 Attendance
korsana.com
Biotech companies
Biotech developing medicines for neurodegenerative diseases that are engineered to cross the blood–brain barrier.
Session
Mon Nov 16
9:00am–12:00pm
Beyond the Vessel Wall: Translational Insights into Vascular Inflammation (S03)
Pathology · Translational safety · with Labcorp
  1. 9:00amIntroduction to Vascular Inflammation (S03-1)Korsana Biosciences
  2. 9:15amDrug Induced Vascular Injury (DIVI) Related to Biologic Therapies: Mechanisms and Sensitivity (S03-2)International Academy of Toxicologic Pathology
  3. 9:45amA Regulatory Perspective (S03-3)ToxStrategies
  4. 10:45amBiomarkers of Vascular Injury (S03-4)Merck
  5. 11:15amInnovative Tools and Future Directions (S03-5)Kymera Therapeutics
Talk
Mon Nov 16
9:00am–9:15am
Part of Beyond the Vessel Wall: Translational Insights into Vascular Inflammation (S03)
Introduction to Vascular Inflammation (S03-1)
Pathology

Explore the full ACT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full ACT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Korsana Biosciences

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction